GE Healthcare and Germfree are joining expertise to develop a fully integrated, expandable manufacturing solution for emerging biotherapeutics, including gene therapy.
The manufacturing solution will feature a Germfree modular bioprocessing environment based on GE Healthcare's proprietary design and equipped with FlexFactory™, GE Healthcare's integrated single-use biomanufacturing platform. This will be the latest addition to GE Healthcare's KUBio™ prefabricated manufacturing facility offering.
"With Germfree, we will bring reliable and scalable technologies for modular solutions to the gene therapy space," said Olivier Loeillot, General Manager, BioProcess at GE Healthcare. "Modular capabilities can reduce timelines, lower capital and operating costs, as well as give flexibility for potential expansion.”
"The collaboration with GE Healthcare provides rapidly deployable process-ready cleanroom and bioprocessing platforms to an industry where resource constraints limit the progress of emerging biotherapeutics,” Carol Houts, Germfree's Vice President, Quality and Business Strategy said “Germfree has longstanding global expertise in producing biocontainment environments and biotherapeutics cleanroom solutions."